Tumor Biology

, Volume 37, Issue 3, pp 3025–3031 | Cite as

BMP10 inhibited the growth and migration of gastric cancer cells

  • Haiming Lei
  • Jian Wang
  • Peihua Lu
  • Xinghua Si
  • Koulan Han
  • Tingyan Ruan
  • Junjie Lu
Original Article


Bone morphogenetic protein 10 (BMP10), a novel member of BMP family, has been identified as an important regulator for angiogenesis. Dysregulation of BMP has been observed in several cancer types. However, its roles in gastric cancer (GC) remain unknown. In this study, the expression of BMP10 was found to be down-regulated in GC samples. Forced expression of BMP10 in GC cells inhibited its growth and migration, while knocking down the expression of BMP10 in GC cells promoted cell growth, migration, and metastasis. BMP10 was shown to negatively regulated beta-catenin/TCF signaling by up-regulating Axin protein level. Taken together, the present study revealed the suppressive function of BMP10 in gastric cancer.


BMP10 Beta-catenin/TCF signaling Axin Cell growth and migration 


Compliance with ethical standards

Conflicts of interest



  1. 1.
    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012;149:1192–205.CrossRefPubMedGoogle Scholar
  3. 3.
    Macdonald BT, Semenov MV, He X. Snapshot: Wnt/beta-catenin signaling. Cell. 2007;131:1204.CrossRefPubMedGoogle Scholar
  4. 4.
    Bazas VM, Lukyanova NY, Lisovenko GS, Rozumiy DO, Potebnya GP. Postoperative autovaccinotherapy for patients with gastric cancer and expression of some proteins in tumor tissue. Exp Oncol. 2009;31:182–4.PubMedGoogle Scholar
  5. 5.
    Schuetz JM, Leach S, Kaurah P, et al. Catenin family genes are not commonly mutated in hereditary diffuse gastric cancer. Cancer Epidemiol Biomarkers Prev. 2012;21:2272–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Pan KF, Liu WG, Zhang L, You WC, Lu YY. Mutations in components of the wnt signaling pathway in gastric cancer. World J Gastroenterol. 2008;14:1570–4.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Kimelman D, Pyati UJ. Bmp signaling: turning a half into a whole. Cell. 2005;123:982–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Brosens LA, Langeveld D, van Hattem WA, Giardiello FM, Offerhaus GJ. Juvenile polyposis syndrome. World J Gastroenterol. 2011;17:4839–44.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Oshima H, Oguma K, Du YC, Oshima M. Prostaglandin e2, wnt, and bmp in gastric tumor mouse models. Cancer Sci. 2009;100:1779–85.CrossRefPubMedGoogle Scholar
  10. 10.
    Ricard N, Ciais D, Levet S, et al. Bmp9 and bmp10 are critical for postnatal retinal vascular remodeling. Blood. 2012;119:6162–71.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Huang J, Elicker J, Bowens N, et al. Myocardin regulates bmp10 expression and is required for heart development. J Clin Invest. 2012;122:3678–91.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of bmp9 and bmp10 as functional activators of the orphan activin receptor-like kinase 1 (alk1) in endothelial cells. Blood. 2007;109:1953–61.CrossRefPubMedGoogle Scholar
  13. 13.
    Alt A, Miguel-Romero L, Donderis J, et al. Structural and functional insights into endoglin ligand recognition and binding. PLoS One. 2012;7:e29948.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Mazerbourg S, Hsueh AJ. Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update. 2006;12:373–83.CrossRefPubMedGoogle Scholar
  15. 15.
    Zhang N, Ye L, Wu L, et al. Expression of bone morphogenetic protein-10 (bmp10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro. Anticancer Res. 2013;33:1917–25.PubMedGoogle Scholar
  16. 16.
    Ye L, Bokobza S, Li J, et al. Bone morphogenetic protein-10 (bmp-10) inhibits aggressiveness of breast cancer cells and correlates with poor prognosis in breast cancer. Cancer Sci. 2010;101:2137–44.CrossRefPubMedGoogle Scholar
  17. 17.
    Kang MH, Oh SC, Lee HJ, et al. Metastatic function of bmp-2 in gastric cancer cells: the role of pi3k/akt, mapk, the nf-kappab pathway, and mmp-9 expression. Exp Cell Res. 2011;317:1746–62.CrossRefPubMedGoogle Scholar
  18. 18.
    Aoki M, Ishigami S, Uenosono Y, et al. Expression of bmp-7 in human gastric cancer and its clinical significance. Br J Cancer. 2011;104:714–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Park Y, Kim JW, Kim DS, et al. The bone morphogenesis protein-2 (bmp-2) is associated with progression to metastatic disease in gastric cancer. Cancer Res Treat. 2008;40:127–32.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Katoh M, Terada M. Overexpression of bone morphogenic protein (bmp)-4 mrna in gastric cancer cell lines of poorly differentiated type. J Gastroenterol. 1996;31:137–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Kang MH, Kim JS, Seo JE, Oh SC, Yoo YA. Bmp2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (pi3k)/akt pathway. Exp Cell Res. 2010;316:24–37.CrossRefPubMedGoogle Scholar
  22. 22.
    Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer: Crosstalk between wnt, bmp, hedgehog and notch. Cell Cycle. 2012;11:4344–51.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Villacorte M, Suzuki K, Hayashi K, et al. Antagonistic crosstalk of wnt/beta-catenin/bmp signaling within the apical ectodermal ridge (aer) regulates interdigit formation. Biochem Biophys Res Commun. 2010;391:1653–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Liu Z, Tang Y, Qiu T, Cao X, Clemens TL. A dishevelled-1/smad1 interaction couples wnt and bone morphogenetic protein signaling pathways in uncommitted bone marrow stromal cells. J Biol Chem. 2006;281:17156–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Tian YC, Phillips AO. Interaction between the transforming growth factor-beta type ii receptor/smad pathway and beta-catenin during transforming growth factor-beta1-mediated adherens junction disassembly. Am J Pathol. 2002;160:1619–28.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Haiming Lei
    • 1
  • Jian Wang
    • 2
  • Peihua Lu
    • 3
  • Xinghua Si
    • 1
  • Koulan Han
    • 1
  • Tingyan Ruan
    • 3
  • Junjie Lu
    • 4
  1. 1.Department of Clinical MedicineYancheng Institute of Health SciencesYanchengChina
  2. 2.Department of Gastrointestinal SurgeryHuai’an Hospital Affiliated of Xuzhou Medical College and Huai’an Second People’s HospitalHuai’anChina
  3. 3.Department of Medical OncologyWuxi People’s Hospital Affiliated to Nanjing Medical UniversityWuxiChina
  4. 4.Department of Critical Care MedicineAffiliated Yixing People’s Hospital, Jiangsu UniversityYixingChina

Personalised recommendations